Eyevance Pharmaceuticals

Biotech · Private

Ophthalmic pharmaceutical therapeutics for dry eye and retinal diseases

eyevance.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
2
0 granted · 2 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1478ACHERX LLC——
1479General LED, Inc.—$941K
1480Arch Biopartners Inc.—$631K
1481Eyevance Pharmaceuticals——
1482PROTHERA BIOLOGICS, INC.—$250K
1483Modulate Bio Inc.—$200K
1484Aperta Biosciences, LLC—$175K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Ocular Lubricant Formulationsapplication
  • Ocular Lubricant Formulationsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.